Abeona Therapeutics (ABEO) Total Liabilities (2010 - 2026)

Abeona Therapeutics' Total Liabilities history runs 17 years deep, the most recent figure standing at $53.6 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 7.61% year-over-year to $53.6 million; the TTM figure through Mar 2026 stood at $53.6 million (down 7.61% YoY), while the FY2025 annual figure was $60.4 million, down 7.0% from the prior year.
• Total Liabilities was $53.6 million for Q1 2026 at Abeona Therapeutics, down from $60.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $83.7 million in Q1 2024 to a low of $23.3 million in Q3 2022.
• Historically, Total Liabilities has averaged $51.8 million across 5 years, with a median of $53.6 million in 2026.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities tumbled 49.56% in 2022, then jumped 141.9% in 2024.
• A 5-year view of Total Liabilities shows it stood at $37.5 million in 2022, then soared by 31.3% to $49.2 million in 2023, then jumped by 31.97% to $64.9 million in 2024, then retreated by 7.0% to $60.4 million in 2025, then retreated by 11.27% to $53.6 million in 2026.
• The last three Total Liabilities figures came in at $53.6 million (Q1 2026), $60.4 million (Q4 2025), and $59.9 million (Q3 2025), per Business Quant data.